Novel Prostate Cancer Biomarkers Derived from Autoantibody Signatures
BACKGROUND: Due to the low specificity of the prostate-specific antigen (PSA) assay and a high false positive rate, a large number of prostate cancer (PCA) biopsies are performed unnecessarily. Consequently, there is a need for new biomarkers that can identify PCA at any stage of progression while l...
| Published in: | Translational Oncology |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2015-04-01
|
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523315000121 |